
Neuland Laboratories Limited – NSE:NEULANDLAB.NS
Neuland Laboratories Limited stock price today
Neuland Laboratories Limited stock price monthly change
Neuland Laboratories Limited stock price quarterly change
Neuland Laboratories Limited stock price yearly change
Neuland Laboratories Limited key metrics
Market Cap | 177.08B |
Enterprise value | 176.16B |
P/E | 62.85 |
EV/Sales | 11.52 |
EV/EBITDA | 39.06 |
Price/Sales | 11.50 |
Price/Book | 12.59 |
PEG ratio | 0.62 |
EPS | 233.89 |
Revenue | 15.58B |
EBITDA | 4.69B |
Income | 3.00B |
Revenue Q/Q | -5.41% |
Revenue Y/Y | 30.84% |
Profit margin | 18.3% |
Oper. margin | 20.01% |
Gross margin | 41.13% |
EBIT margin | 20.01% |
EBITDA margin | 30.14% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNeuland Laboratories Limited stock price history
Neuland Laboratories Limited stock forecast
Neuland Laboratories Limited financial statements
Jun 2023 | 3.62B | 618.79M | 17.05% |
---|---|---|---|
Sep 2023 | 4.17B | 892.47M | 21.36% |
Dec 2023 | 3.92B | 813.90M | 20.72% |
Mar 2024 | 3.85B | 675.61M | 17.55% |
2026 | 19.13B | 3.75B | 19.62% |
---|---|---|---|
2027 | 22.71B | 5.00B | 22.04% |
Analysts Price target
Financials & Ratios estimates
Payout ratio | 0% |
---|
2016 | 0.26% |
---|---|
2017 | 0.13% |
2019 | |
2020 | 1.36% |
2022 | 0.29% |
Jun 2023 | 0 | 0 | |
---|---|---|---|
Sep 2023 | 16650570000 | 5.32B | 31.97% |
Dec 2023 | 0 | 0 | |
Mar 2024 | 18325610000 | 5.49B | 30% |
Jun 2023 | 271.71M | 0 | 0 |
---|---|---|---|
Sep 2023 | 290.15M | 0 | 0 |
Dec 2023 | 302.87M | 0 | 0 |
Mar 2024 | 0 | 0 | 0 |
Neuland Laboratories Limited alternative data
Aug 2023 | 1,554 |
---|---|
Sep 2023 | 1,554 |
Oct 2023 | 1,554 |
Nov 2023 | 1,554 |
Dec 2023 | 1,554 |
Jan 2024 | 1,554 |
Feb 2024 | 1,554 |
Mar 2024 | 1,554 |
Apr 2024 | 1,554 |
May 2024 | 1,554 |
Jun 2024 | 1,554 |
Jul 2024 | 1,554 |
Neuland Laboratories Limited other data
Insider | Compensation |
---|---|
Dr. Davuluri Rama Mohan Rao (1944) Executive Chairman & Chief Promoter | $38,560,000 |
Mr. Davuluri Sucheth Rao (1975) Vice Chairman & Chief Executive Officer | $34,350,000 |
Mr. Davuluri Saharsh Rao (1979) Vice Chairman & Joint MD | $32,350,000 |
-
What's the price of Neuland Laboratories Limited stock today?
One share of Neuland Laboratories Limited stock can currently be purchased for approximately $1,551.75.
-
When is Neuland Laboratories Limited's next earnings date?
Unfortunately, Neuland Laboratories Limited's (NEULANDLAB.NS) next earnings date is currently unknown.
-
Does Neuland Laboratories Limited pay dividends?
Yes, Neuland Laboratories Limited pays dividends and its trailing 12-month yield is 0.1% with 0% payout ratio. The last Neuland Laboratories Limited stock dividend of $0 was paid on 12 Sep 2025.
-
How much money does Neuland Laboratories Limited make?
Neuland Laboratories Limited has a market capitalization of 177.08B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 68.44% to 15.59B US dollars.
-
What is Neuland Laboratories Limited's stock symbol?
Neuland Laboratories Limited is traded on the NSE under the ticker symbol "NEULANDLAB.NS".
-
What is Neuland Laboratories Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Neuland Laboratories Limited?
Shares of Neuland Laboratories Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Neuland Laboratories Limited's key executives?
Neuland Laboratories Limited's management team includes the following people:
- Dr. Davuluri Rama Mohan Rao Executive Chairman & Chief Promoter(age: 81, pay: $38,560,000)
- Mr. Davuluri Sucheth Rao Vice Chairman & Chief Executive Officer(age: 50, pay: $34,350,000)
- Mr. Davuluri Saharsh Rao Vice Chairman & Joint MD(age: 46, pay: $32,350,000)
-
How many employees does Neuland Laboratories Limited have?
As Jul 2024, Neuland Laboratories Limited employs 1,554 workers.
-
When Neuland Laboratories Limited went public?
Neuland Laboratories Limited is publicly traded company for more then 16 years since IPO on 13 Oct 2008.
-
What is Neuland Laboratories Limited's official website?
The official website for Neuland Laboratories Limited is neulandlabs.com.
-
How can i contact Neuland Laboratories Limited?
Neuland Laboratories Limited can be reached via phone at +91 40 6761 1600.
Neuland Laboratories Limited company profile:

Neuland Laboratories Limited
neulandlabs.comNSE
1,643
Drug Manufacturers - Specialty & Generic
Healthcare
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India.
Hyderabad, 500033
:
ISIN: INE794A01010
CUSIP: Y6272R119